From the press release:
In a linked editorial, Professor Hedvig Nordeng and colleagues from the University of Oslo emphasise that long term neurodevelopmental outcomes are needed to understand the safety of drugs taken during pregnancy. “Observational studies, for all their flaws, are a necessary piece of the puzzle, and healthcare databases such as the one used for this study provide a rich resource, particularly if they are augmented by additional data sources to reduce confounding,” they write.
Read the main article here.
